Marshall Wace, LLP Zynex Inc Transaction History

Marshall Wace, LLP

$78.4 Billion
Q4 2024

A detailed history of Marshall Wace, LLP transactions in Zynex Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 110,429 shares of ZYXI stock, worth $830,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

110,429

Previous 111,581 1.03%

Holding current value

$830,426

Previous $910,000 2.86%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$7.51 - $9.3 $8,651 - $10,713	-1,152 Reduced 1.03%	110,429 $884,000
Q3 2024 Nov 14, 2024	SELL	$7.19 - $10.31 $706,661 - $1.01 Million	-98,284 Reduced 46.83%	111,581 $910,000
Q2 2024 Aug 14, 2024	SELL	$8.63 - $12.56 $468,807 - $682,296	-54,323 Reduced 20.56%	209,865 $1.96 Million
Q1 2024 May 15, 2024	SELL	$9.86 - $13.74 $356,547 - $496,852	-36,161 Reduced 12.04%	264,188 $3.27 Million
Q4 2023 Feb 14, 2024	BUY	$7.1 - $10.89 $609,584 - $934,982	85,857 Added 40.03%	300,349 $3.27 Million
Q3 2023 Nov 14, 2023	BUY	$6.95 - $9.89 $1.13 Million - $1.6 Million	162,164 Added 309.9%	214,492 $1.72 Million
Q2 2023 Aug 14, 2023	SELL	$8.59 - $14.56 $860,872 - $1.46 Million	-100,218 Reduced 65.7%	52,328 $501,000
Q1 2023 May 15, 2023	BUY	$9.53 - $16.8 $1.45 Million - $2.56 Million	152,546 New	152,546 $1.83 Million
Q2 2022 Aug 15, 2022	SELL	$5.78 - $8.87 $570,040 - $874,786	-98,623 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.14 - $9.35 $506,922 - $922,125	98,623 New	98,623 $615,000
Q4 2021 Feb 14, 2022	SELL	$8.71 - $13.77 $131,904 - $208,532	-15,144 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.35 - $15.65 $156,740 - $237,003	15,144 New	15,144 $172,000

Others Institutions Holding ZYXI

# of Institutions

Shares Held

7.9M

Call Options Held

3.1K

Put Options Held

7.5K

View Full List

About ZYNEX INC

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $282M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

More about ZYXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Zynex Inc Transaction History